KalVista Pharmaceuticals (KALV) Earnings Date & Reports

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

KALV is expected to report earnings to fall 3.17% to -95 cents per share on September 04

KalVista Pharmaceuticals KALV Stock Earnings Reports

Q3'25

Est.

$-0.96

Q2'25

Missed

by $0.14

Q1'25

Missed

by $0.05

Q4'24

Beat

by $0.02

Q3'24

Beat

by $0.03

The last earnings report on July 10 showed earnings per share of -99 cents, missing the estimate of -84 cents. With 298.41K shares outstanding, the current market capitalization sits at 777.28M.

View a ticker or compare two or three

Compare

KALV